Update 1/26/23: Evusheld is no longer authorized for use in the U.S. due to the high proportion of resistant SARS-CoV-2 variants. Patients should be advised to:
- Keep up to date with COVID-19 vaccination and boosters, unless contraindicated.
- Take precautions to avoid infection.
- Be tested for SARS-CoV-2 if they experience signs and symptoms consistent with COVID-19 and, if infected, promptly seek medical attention. For outpatient treatment options, visit https://www.bjc.org/for-physicians/covid.